Safety, Tolerability, and Pharmacokinetics (PK) of Single and Multiple Ascending Oral Doses of iQ-007

Clinical trial NCT06899230 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06899230
Sponsor: iQure Australia Pty Ltd
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Drug Resistant Epilepsy Focal Seizure

Start date: 2025-04-08
Primary completion: 2026-01-29
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.